Thursday, 2 June 2022

Vaccination during pregnancy cuts infant infections; vaccines only modestly reduce long COVID risk

Vaccination during pregnancy cuts infant infections; vaccines only modestly reduce long COVID risk

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

Vaccinations of young children could begin 'in earnest' by June 21 -White House

The White House expects vaccinations of young children to begin in earnest as early as June 21, if federal authorities approve their use in coming weeks, White House COVID response coordinator Ashish Jha said on Thursday.

Developing world should reap benefits of new monkeypox research, experts urge

As cases of monkeypox in wealthier Western nations spark a flurry of scientific research to combat the outbreak, scientists are urging the world to make sure lower-income nations benefit from the fruits of that labor as well.

Pfizer's Paxlovid reduces COVID risk in seniors regardless of vaccine status -study

Pfizer Inc's antiviral treatment Paxlovid reduces COVID-19 hospitalization and death rates in vaccinated and unvaccinated patients 65 years and older, according to a new study in Israel conducted during the rise of the Omicron variant of the coronavirus.

France says number of confirmed monkeypox cases has risen to 33

The number of confirmed monkeypox cases in France has risen to 33 from 17 earlier this week, health authorities said on Thursday.

Japan study shows women more likely to get skin rash from Moderna shot

A study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc's COVID-19 vaccine.

Bristol Myers, J&J drugs reduce COVID death rates in NIH study

A late-stage study of two rheumatoid arthritis drugs from Bristol Myers Squibb and Johnson & Johnson showed a significant drop in deaths among hospitalized COVID patients, a U.S. health agency said on Thursday.

Fresenius plans to cut 2,000 jobs globally at Kabi unit - Handelsblatt

Healthcare group Fresenius SE plans to cut 2,000 jobs globally at its generic drugs unit Kabi, or around 5% of the unit's workforce, as part of an efficiency programme, business daily Handelsblatt reported on Thursday.

Federal investigators to review FDA response to baby formula recall

Federal investigators have launched a review into whether the U.S. Food and Drug Administration properly inspected Abbott Laboratories' Michigan plant and how the agency oversaw the baby formula recall that led to severe U.S. shortages.

New vaccine plant in Senegal gets 75 million euros from EIB

The European Investment Bank (EIB) committed 75 million euros ($80 million) on Thursday to finance construction of a new facility in Senegal that will produce COVID-19 and other vaccines for use across Africa.

Related Videos

Monkeypox "will not be like COVID" - Spanish microbiologist

Monkeypox can be contained if we act now: WHO

N.Korea reports more deaths amid COVID lockdown

at